135 related articles for article (PubMed ID: 24330593)
1. Multiple mechanisms underlying the long duration of action of thienorphine, a novel partial opioid agonist for the treatment of addiction.
Yu G; Li SH; Cui MX; Yan LD; Yong Z; Zhou PL; Su RB; Gong ZH
CNS Neurosci Ther; 2014 Mar; 20(3):282-8. PubMed ID: 24330593
[TBL] [Abstract][Full Text] [Related]
2. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
Yu G; Yue YJ; Cui MX; Gong ZH
J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
[TBL] [Abstract][Full Text] [Related]
3. Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.
Zhou PL; Li YL; Yan LD; Yong Z; Yu G; Dong HJ; Yan H; Su RB; Gong ZH
World J Gastroenterol; 2013 Mar; 19(9):1444-50. PubMed ID: 23539497
[TBL] [Abstract][Full Text] [Related]
4. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
Li JX; Becker GL; Traynor JR; Gong ZH; France CP
J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
[TBL] [Abstract][Full Text] [Related]
5. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
[TBL] [Abstract][Full Text] [Related]
6. Effects of thienorphine on the contraction of isolated ureter and bladder of guinea pigs.
Zhou P; Li Y; Yong Z; Yan H; Su R; Gong Z
Eur J Pharmacol; 2016 Oct; 789():144-151. PubMed ID: 27445237
[TBL] [Abstract][Full Text] [Related]
7. Effects of thienorphine on contraction of the guinea pig sphincter of Oddi, choledochus and gall bladder.
Zhou P; Li T; Su R; Gong Z
Eur J Pharmacol; 2014 Aug; 737():22-8. PubMed ID: 24830319
[TBL] [Abstract][Full Text] [Related]
8. [Structure-activity relationships analysis of thienorphine and its derivatives].
Yu G; Liu YS; Yan LD; Wen Q; Gong ZH
Yao Xue Xue Bao; 2009 Jul; 44(7):726-30. PubMed ID: 19806910
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
Wen Q; Yu G; Li YL; Yan LD; Gong ZH
Acta Pharmacol Sin; 2011 Oct; 32(10):1215-24. PubMed ID: 21863064
[TBL] [Abstract][Full Text] [Related]
10. Effect of thienorphine on the isolated uterine strips from pregnant rats.
Zhou P; Yan L; Yong Z; Yu G; Dong H; Yan H; Su R; Gong Z
Eur J Pharmacol; 2013 Mar; 703(1-3):83-90. PubMed ID: 23416213
[TBL] [Abstract][Full Text] [Related]
11. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
12. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
[TBL] [Abstract][Full Text] [Related]
14. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
[TBL] [Abstract][Full Text] [Related]
15. Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations.
Kajiwara M; Aoki K; Ishii K; Numata H; Matsumiya T; Oka T
Jpn J Pharmacol; 1986 Jan; 40(1):95-101. PubMed ID: 3007830
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic thienorphine administration on long-term potentiation and synaptic structure in rat hippocampus.
Yong Z; Yan L; Dong Z; Wang X; Su R; Gong Z
Synapse; 2013 Nov; 67(11):779-85. PubMed ID: 23723052
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of monoamine oxidase activity in the striatum of rats following chronic treatment of thienorphine.
Yong Z; Yan L; Wang X; Su R; Gong Z
Eur J Pharmacol; 2013 Aug; 713(1-3):44-6. PubMed ID: 23665497
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
20. Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay.
Romero DV; Partilla JS; Zheng QX; Heyliger SO; Ni Q; Rice KC; Lai J; Rothman RB
Synapse; 1999 Nov; 34(2):83-94. PubMed ID: 10502307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
